Related Experiment Video
Updated: May 25, 2025

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Obesity with developmental delay in infancy: a rare cause not to miss-pseudohypoparathyroidism
Anees F M Ahmed1, Rine Benson Thobias1, Nilavan Thirumavalavan1
1Department of Paediatrics, Saveetha Medical College, Chennai, Tamil Nadu, India.
Insights
Infants with obesity and developmental delay may have underlying conditions like pseudohypoparathyroidism (PHP). Early diagnosis and comprehensive management, including medical treatment and developmental interventions, are crucial for correcting delays.
Area of Science:
- Pediatrics
- Endocrinology
- Developmental Biology
Background:
- Obesity in infants can mask or be misattributed to developmental delays.
- Gross motor delay, seizures, and obstructive sleep apnea in infants warrant thorough investigation.
Purpose of the Study:
- To highlight the importance of recognizing pseudohypoparathyroidism (PHP) in infants presenting with obesity and developmental delay.
- To emphasize the need for comprehensive management beyond addressing developmental aspects alone.
Main Methods:
- Case report of an infant with obesity, gross motor delay, seizures, and obstructive sleep apnea.
- Diagnosis of pseudohypoparathyroidism (PHP) confirmed.
- Medical management with calcium, vitamin D, and magnesium.
- Coordinated early intervention by developmental therapists and pediatricians.
Main Results:
- The infant diagnosed with pseudohypoparathyroidism (PHP) showed corrected developmental delay through integrated medical and therapeutic interventions.
- Successful management involved parenteral calcium, vitamin D, magnesium, and tailored developmental therapies.
Conclusions:
- Early recognition of correctable conditions like pseudohypoparathyroidism (PHP) is vital in infants with obesity and developmental concerns.
- Comprehensive management by developmental specialists, addressing both the underlying condition and developmental needs, leads to improved outcomes.
Abstract:
Mild developmental delay in infants with obesity is often disregarded, attributing it to increased weight by parents and practitioners. We report an infant with obesity and gross motor delay after the first 6 months of age, seizures and obstructive sleep apnoea. The child was diagnosed with pseudohypoparathyroidism (PHP) and was medically managed with parenteral calcium, vitamin D and magnesium. Appropriate early interventions by developmental therapists addressing the developmental domains coordinated by developmental paediatricians and relevant drug and diet management corrected the delay. The child is followed up for soft tissue calcifications, kidney functions and skeletal health. This case highlights the importance of early recognition and comprehensive management of correctable conditions like PHP by developmental specialists rather than addressing only the developmental aspect of it.
More Related Videos
07:12Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Inborn Errors of Metabolism
Obesity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Bulimia Nervosa
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...